Patients with GCA receiving combination IVMP/MTX with lower-dose prednisone had lower cumulative GC doses and fewer related side effects vs SOC.
Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback